Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

CMV Antibody (0898): sc-58118

2.0(1)
Write a reviewAsk a question

Datasheets
  • CMV Antibody (0898) is a mouse monoclonal IgG2a, cited in 2 publications, provided at 100 µg/ml
  • raised against CMV
  • recommended for detection of a 65 kD structural late antigen of CMV origin by WB and IF
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for CMV Antibody (0898). This work is in progress.

QUICK LINKS

SEE ALSO...

CMV Antibody (0898) is a mouse monoclonal IgG2a antibody that detects cytomegalovirus (CMV) by western blotting (WB) and immunofluorescence (IF). Anti-CMV antibody (0898) is available in a non-conjugated form, providing flexibility for various experimental needs. Cytomegalovirus, a member of the herpes virus family, remains dormant in the body for extended periods, posing risks to immunocompromised individuals and fetuses. The 65 kD structural late antigen targeted by CMV monoclonal antibody (0898) plays a crucial role in the viral life cycle, as this protein is involved in the assembly and release of viral particles, making CMV (0898) antibody essential for understanding CMV pathogenesis and developing therapeutic strategies. CMV resides in various body fluids, including saliva, urine, and blood, and CMV infection can lead to severe complications, especially in vulnerable populations. Using CMV (0898) monoclonal antibody in research can provide valuable insights into viral behavior and impact, ultimately contributing to advancements in clinical and therapeutic approaches.

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

CMV Antibody (0898) References:

  1. Role of cytomegalovirus infection in allograft rejection: a review of possible mechanisms.  |  Borchers, AT., et al. 1999. Transpl Immunol. 7: 75-82. PMID: 10544437
  2. Cytomegalovirus infection in normal and immunocompromised humans. A review.  |  Drago, F., et al. 2000. Dermatology. 200: 189-95. PMID: 10828625
  3. Congenital cytomegalovirus infection: review of the epidemiology and outcome.  |  Gaytant, MA., et al. 2002. Obstet Gynecol Surv. 57: 245-56. PMID: 11961482
  4. Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion.  |  Fletcher, JM., et al. 2005. J Immunol. 175: 8218-25. PMID: 16339561
  5. Diagnosis of cutaneous cytomegalovirus infection: a review and report of a case.  |  Toome, BK., et al. 1991. J Am Acad Dermatol. 24: 860-7. PMID: 1646834
  6. Congenital and perinatal cytomegalovirus infections.  |  Alford, CA., et al. 1990. Rev Infect Dis. 12 Suppl 7: S745-53. PMID: 2173104
  7. Impact of cytomegalovirus infection on organ transplant recipients.  |  Rubin, RH. 1990. Rev Infect Dis. 12 Suppl 7: S754-66. PMID: 2173105
  8. Cytomegalovirus infection following liver transplantation: review of the literature.  |  Kanj, SS., et al. 1996. Clin Infect Dis. 22: 537-49. PMID: 8852975
  9. Quantitation of cytomegalovirus: methodologic aspects and clinical applications.  |  Boeckh, M. and Boivin, G. 1998. Clin Microbiol Rev. 11: 533-54. PMID: 9665982

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

CMV Antibody (0898)

sc-58118
100 µg/ml
$316.00